Vaxcyte, Inc. (PCVX)
61.18
+0.09
(+0.15%)
USD |
NASDAQ |
Aug 27, 16:00
61.18
0.00 (0.00%)
After-Hours: 20:00
Vaxcyte Market Cap : 8.858B for Aug. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 8.845B |
| August 25, 2026 | 8.845B |
| August 24, 2026 | 8.958B |
| August 21, 2026 | 9.066B |
| August 20, 2026 | 8.881B |
| August 19, 2026 | 9.165B |
| August 18, 2026 | 8.657B |
| August 17, 2026 | 8.719B |
| August 14, 2026 | 8.408B |
| August 13, 2026 | 8.522B |
| August 12, 2026 | 8.636B |
| August 11, 2026 | 8.574B |
| August 10, 2026 | 8.440B |
| August 07, 2026 | 8.408B |
| August 06, 2026 | 8.526B |
| August 05, 2026 | 8.096B |
| August 04, 2026 | 7.918B |
| August 03, 2026 | 7.750B |
| July 31, 2026 | 7.805B |
| July 30, 2026 | 8.076B |
| July 29, 2026 | 7.646B |
| July 28, 2026 | 7.880B |
| July 27, 2026 | 8.009B |
| July 24, 2026 | 7.888B |
| July 23, 2026 | 8.030B |
| Date | Value |
|---|---|
| July 22, 2026 | 8.082B |
| July 21, 2026 | 8.376B |
| July 20, 2026 | 8.009B |
| July 17, 2026 | 8.111B |
| July 16, 2026 | 8.087B |
| July 15, 2026 | 8.188B |
| July 14, 2026 | 8.112B |
| July 13, 2026 | 8.230B |
| July 10, 2026 | 8.401B |
| July 09, 2026 | 8.634B |
| July 08, 2026 | 8.473B |
| July 07, 2026 | 8.756B |
| July 06, 2026 | 8.220B |
| July 02, 2026 | 8.427B |
| July 01, 2026 | 8.093B |
| June 30, 2026 | 8.389B |
| June 29, 2026 | 8.330B |
| June 26, 2026 | 8.157B |
| June 25, 2026 | 7.747B |
| June 24, 2026 | 7.774B |
| June 23, 2026 | 7.499B |
| June 22, 2026 | 7.520B |
| June 18, 2026 | 7.424B |
| June 17, 2026 | 7.312B |
| June 16, 2026 | 7.116B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 56.96B |
| Arrowhead Pharmaceuticals, Inc. | 12.50B |
| Oncolytics Biotech, Inc. | 105.95M |
| Sangamo Therapeutics, Inc. | 62.35M |
| Sarepta Therapeutics, Inc. | 2.280B |
Market Cap Related Metrics
| PEG Ratio | -0.0946 |
| Price to Book Value | 3.212 |
| Price | 61.18 |
| Earnings Yield | -12.60% |
| PEGY Ratio | -0.0946 |